BHVN Stock Summary and Trading Ideas (Biohaven Ltd. Common Shares | NYSE:BHVN)

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Biohaven Ltd. Common Shares trades on the NYSE stock market under the symbol BHVN.

As of July 31, 2026, BHVN stock price declined to $13.50 with 1,322,049 million shares trading.

BHVN has a beta of 1.98, meaning it tends to be more sensitive to market movements. BHVN has a correlation of 0.06 to the broad based SPY ETF.

BHVN has a market cap of $2.03 billion. This is considered a Mid Cap stock.

Last quarter Biohaven Ltd. Common Shares reported $0 in Revenue and -$.69 earnings per share. This fell short of revenue expectation by $-8 million and exceeded earnings estimates by $.09.

In the last 3 years, BHVN traded as high as $62.21 and as low as $7.48.

The top ETF exchange traded funds that BHVN belongs to (by Net Assets): XBI, IWM, VXF, IWO, IBB.

BHVN has underperformed the market in the last year with a price return of -13.5% while the SPY ETF gained +18.9%. However, in the short term, BHVN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +40.8% vs +4.2% return in SPY. But in the last 2 weeks, BHVN shares have been beat by the market, returning -4.7% compared to an SPY return of -0.5%.

BHVN support price is $13.18 and resistance is $14.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHVN shares will trade within this expected range on the day.